Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) in the Asia Pacific region (Round Table Forum)

Tin Tin Su, Awang M. Bulgiba, Pichet Sampatanukul, Sudigdo Sastroasmoro, Peter Chang, Prathap Tharyan, Vivian Lin, Yut Lin Wong

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) have become increasingly important in an era of rising costs, patient safety concerns and evidence-based health care. CE and EBM research in the Asia Pacific region have grown significantly. However, there are three main challenges such as linking evidence to practice and policy; developing a strong collaborative network; and a need for resources and technical expertise to produce evidence. The Cochrane Collaboration is a possible solution to resolve above challenges identified, particularly the challenge of transforming evidence to practice. In addition, training can be carried out to enhance technical expertise in the region and there is also the promising potential that collaborations could extend beyond systematic reviews. To improve the adoption of evidence-based health policy, selection of the best evidence for the right audience and focusing on the relevant issues through appropriate methodology are essential. Information on effectiveness and cost effectiveness needs to be highlighted for policy makers. The way forward to strengthen research and capacity building is to establish the Asia Pacific Consortium for CE and EBM. The consortium would help to create mutually rewarding scientific research and collaborations that will augur well for advances in CE and EBM.

Original languageEnglish
JournalPreventive Medicine
Volume57
Issue numberSUPPL
DOIs
Publication statusPublished - 2013

Fingerprint

Evidence-Based Medicine
Epidemiology
Professional Competence
Research
Capacity Building
Evidence-Based Practice
Patient Safety
Health Policy
Administrative Personnel
Cost-Benefit Analysis
Costs and Cost Analysis

Keywords

  • Asia Pacific
  • Australia
  • Clinical epidemiology
  • Evidence-based medicine
  • Evidence-based policy
  • Indonesia
  • Malaysia
  • Taiwan
  • Thailand

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Su, T. T., Bulgiba, A. M., Sampatanukul, P., Sastroasmoro, S., Chang, P., Tharyan, P., ... Wong, Y. L. (2013). Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) in the Asia Pacific region (Round Table Forum). Preventive Medicine, 57(SUPPL). https://doi.org/10.1016/j.ypmed.2013.04.009

Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) in the Asia Pacific region (Round Table Forum). / Su, Tin Tin; Bulgiba, Awang M.; Sampatanukul, Pichet; Sastroasmoro, Sudigdo; Chang, Peter; Tharyan, Prathap; Lin, Vivian; Wong, Yut Lin.

In: Preventive Medicine, Vol. 57, No. SUPPL, 2013.

Research output: Contribution to journalArticle

Su, TT, Bulgiba, AM, Sampatanukul, P, Sastroasmoro, S, Chang, P, Tharyan, P, Lin, V & Wong, YL 2013, 'Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) in the Asia Pacific region (Round Table Forum)', Preventive Medicine, vol. 57, no. SUPPL. https://doi.org/10.1016/j.ypmed.2013.04.009
Su, Tin Tin ; Bulgiba, Awang M. ; Sampatanukul, Pichet ; Sastroasmoro, Sudigdo ; Chang, Peter ; Tharyan, Prathap ; Lin, Vivian ; Wong, Yut Lin. / Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) in the Asia Pacific region (Round Table Forum). In: Preventive Medicine. 2013 ; Vol. 57, No. SUPPL.
@article{0b78dee29dbf40848dd848a2727bc968,
title = "Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) in the Asia Pacific region (Round Table Forum)",
abstract = "Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) have become increasingly important in an era of rising costs, patient safety concerns and evidence-based health care. CE and EBM research in the Asia Pacific region have grown significantly. However, there are three main challenges such as linking evidence to practice and policy; developing a strong collaborative network; and a need for resources and technical expertise to produce evidence. The Cochrane Collaboration is a possible solution to resolve above challenges identified, particularly the challenge of transforming evidence to practice. In addition, training can be carried out to enhance technical expertise in the region and there is also the promising potential that collaborations could extend beyond systematic reviews. To improve the adoption of evidence-based health policy, selection of the best evidence for the right audience and focusing on the relevant issues through appropriate methodology are essential. Information on effectiveness and cost effectiveness needs to be highlighted for policy makers. The way forward to strengthen research and capacity building is to establish the Asia Pacific Consortium for CE and EBM. The consortium would help to create mutually rewarding scientific research and collaborations that will augur well for advances in CE and EBM.",
keywords = "Asia Pacific, Australia, Clinical epidemiology, Evidence-based medicine, Evidence-based policy, Indonesia, Malaysia, Taiwan, Thailand",
author = "Su, {Tin Tin} and Bulgiba, {Awang M.} and Pichet Sampatanukul and Sudigdo Sastroasmoro and Peter Chang and Prathap Tharyan and Vivian Lin and Wong, {Yut Lin}",
year = "2013",
doi = "10.1016/j.ypmed.2013.04.009",
language = "English",
volume = "57",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "SUPPL",

}

TY - JOUR

T1 - Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) in the Asia Pacific region (Round Table Forum)

AU - Su, Tin Tin

AU - Bulgiba, Awang M.

AU - Sampatanukul, Pichet

AU - Sastroasmoro, Sudigdo

AU - Chang, Peter

AU - Tharyan, Prathap

AU - Lin, Vivian

AU - Wong, Yut Lin

PY - 2013

Y1 - 2013

N2 - Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) have become increasingly important in an era of rising costs, patient safety concerns and evidence-based health care. CE and EBM research in the Asia Pacific region have grown significantly. However, there are three main challenges such as linking evidence to practice and policy; developing a strong collaborative network; and a need for resources and technical expertise to produce evidence. The Cochrane Collaboration is a possible solution to resolve above challenges identified, particularly the challenge of transforming evidence to practice. In addition, training can be carried out to enhance technical expertise in the region and there is also the promising potential that collaborations could extend beyond systematic reviews. To improve the adoption of evidence-based health policy, selection of the best evidence for the right audience and focusing on the relevant issues through appropriate methodology are essential. Information on effectiveness and cost effectiveness needs to be highlighted for policy makers. The way forward to strengthen research and capacity building is to establish the Asia Pacific Consortium for CE and EBM. The consortium would help to create mutually rewarding scientific research and collaborations that will augur well for advances in CE and EBM.

AB - Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) have become increasingly important in an era of rising costs, patient safety concerns and evidence-based health care. CE and EBM research in the Asia Pacific region have grown significantly. However, there are three main challenges such as linking evidence to practice and policy; developing a strong collaborative network; and a need for resources and technical expertise to produce evidence. The Cochrane Collaboration is a possible solution to resolve above challenges identified, particularly the challenge of transforming evidence to practice. In addition, training can be carried out to enhance technical expertise in the region and there is also the promising potential that collaborations could extend beyond systematic reviews. To improve the adoption of evidence-based health policy, selection of the best evidence for the right audience and focusing on the relevant issues through appropriate methodology are essential. Information on effectiveness and cost effectiveness needs to be highlighted for policy makers. The way forward to strengthen research and capacity building is to establish the Asia Pacific Consortium for CE and EBM. The consortium would help to create mutually rewarding scientific research and collaborations that will augur well for advances in CE and EBM.

KW - Asia Pacific

KW - Australia

KW - Clinical epidemiology

KW - Evidence-based medicine

KW - Evidence-based policy

KW - Indonesia

KW - Malaysia

KW - Taiwan

KW - Thailand

UR - http://www.scopus.com/inward/record.url?scp=84880578524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880578524&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2013.04.009

DO - 10.1016/j.ypmed.2013.04.009

M3 - Article

VL - 57

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - SUPPL

ER -